Medicine
Tyenne 80 mg/4 mL injection
Tyenne 80 mg/4 mL injection is a prescription medicine containing Tocilizumab for intravenous use, marketed by Fresenius Kabi, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
TYENNE must be refrigerated at 36°F to 46°F (2ºC to 8ºC). Do not freeze. A…
Key facts
- Active ingredient (INN)
- Tocilizumab
- Brand
- Tyenne
- Strength
- 80 mg/4 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 4 mL
- Marketing authorisation holder
- Fresenius Kabi
- Manufacturer
- Fresenius Kabi
- Origin register
- US FDA, United States
- Storage
- TYENNE must be refrigerated at 36°F to 46°F (2ºC to 8ºC). Do not freeze. A single prefilled syringe (or autoinjector) may be stored at room temperature at or below 86°F (30°C) for a single period of up to 14 days. Protect the vials, syringes and autoinjectors from light by storage in the original package until time of use, and keep syringes and autoinjectors dry. Do not shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AC07 Tocilizumab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 April 2024
- Identifiers
- RxCUI 2679431, 2679438, 2679440 +3DailyMed set ID e400bbe6-43c5-4de6-82b9-cb44ce3cd906NDC 65219-590Application BLA761275
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 65219-590-04 | Fresenius Kabi | 15 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Tocilizumab 80 mg/4 mL injection.
Other strengths and forms of Tocilizumab
Clinical summary
Tocilizumab is an interleukin-6 receptor antagonist indicated for treatment of rheumatoid Arthritis (RA), among other approved uses. It is available as injection for intravenous and subcutaneous use. MedsAcross supplies Tocilizumab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TocilizumabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ACTEMRA prescribing information (Genentech) · U.S. National Library of Medicine, DailyMed
- RoActemra: European public assessment report (EPAR) · European Medicines Agency
- Avtozma: European public assessment report (EPAR) · European Medicines Agency
Need Tyenne 80 mg/4 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.